NLB Skladi, upravljanje premozenja, d.o.o.
Position in TLX — Telix Pharmaceuticals Ltd
CIK 2110897
Ljubljana, 2A
Position in TLX
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$668,740
New position
Shares Held
58,000
first reported quarter
Ownership
0.017%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#17
of 62 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026NLB Skladi, upravljanje premozenja, d.o.o. holds $16,165,282 across 11 Biotechnology names. TLX ranks #6 (4.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
13,181 | $6,547,398 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,895 | $2,428,688 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
8,500 | $1,591,880 | |
| 4 | ARGX |
Argenx SE
|
1,700 | $1,577,209 | |
| 5 | LEGN |
Legend Biotech Corp
|
50,000 | $1,444,000 | |
| 6 | TLX |
Telix Pharmaceuticals Ltd
This page
|
58,000 | $668,740 | |
| 7 | CRSP |
CRISPR Therapeutics AG
|
11,111 | $605,993 | |
| 8 | CTMX |
CytomX Therapeutics, Inc.
|
125,000 | $468,750 |
All Filings in TLX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $668,740 | 58,000 | Shares | Sole | 2026-08-06 | |
| No filing history on record for this holder in this stock. | ||||||